HelmholtzZentrum munich

Connecting genetic risk to disease endpoints through the human blood plasma proteome


Proteome annotation
Locus annotations

Locus 325

Top associations per target

Target cis/​trans Study SNP SNP location Maj/​min allele MAF N βinv seinv Pinv fclog Plog Praw
sLeptin R cis Discovery rs17412403 1:65,942,266 T/C 0.46 997 -0.328 0.043 8.7×10-14 -1.260 4.4×10-18 8.3×10-15
sLeptin R cis Replication rs2025803 1:65,946,506 A/G 0.28 337 -0.408 0.077 2.6×10-7 -1.230 6.3×10-7 4.5×10-7


Regional association plots


Boxplots and histograms for top associations

Leptin receptor (sLeptin R)

inverse-normalized probe levels log2 transformed probe levels raw probe levels
Discovery study
Replication study

Leptin receptor (sLeptin R)

Target (abbrv.) sLeptin R
Target (full name) Leptin receptor
Somalogic ID (Sequence ID) SL003184 (5400-52_3)
Entrez Gene Symbol LEPR
UniProt ID P48357
UniProt Comment
  • Receptor for hormone LEP/leptin (Probable) (PubMed:22405007). On ligand binding, mediates LEP central and peripheral effects through the activation of different signaling pathways such as JAK2/STAT3 and MAPK cascade/FOS. In the hypothalamus, LEP acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones (By similarity) (PubMed:9537324). In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic and affects innate and adaptive immunity (PubMed:25060689, PubMed:12504075, PubMed:8805376). Control of energy homeostasis and melanocortin production (stimulation of POMC and full repression of AgRP transcription) is mediated by STAT3 signaling, whereas distinct signals regulate NPY and the control of fertility, growth and glucose homeostasis. Involved in the regulation of counter-regulatory response to hypoglycemia by inhibiting neurons of the parabrachial nucleus. Has a specific effect on T lymphocyte responses, differentially regulating the proliferation of naive and memory T -ells. Leptin increases Th1 and suppresses Th2 cytokine production (By similarity).
Targeted by drugs (based on IPA annotation)
  • recombinant-methionyl human leptin
Biomarker applications (based on IPA annotation)
  • prognosis
Wiki Pathways
  • AMPK signaling
  • Leptin signaling pathway
Pathway Interaction Database
  • Signaling events mediated by PTP1B
  • Signaling by Leptin

All locus annotations are based on the sentinel SNP (rs17412403) and 19 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)

Linked genes

Genes hit or close-by
Potentially regulated genes
eQTL genes
  • LEPR leptin receptor
  • LEPROT leptin receptor overlapping transcript


Results from other genome-wide association studies

Trait P Study Source
Gene expression of LEPROT///LEPR in blood 1×10-47 21829388 (PMID) GRASP2 eQTL
Gene expression of LEPR in peripheral blood monocytes 2×10-23 20502693 (PMID) GRASP2 eQTL
Gene expression of OBRGRP probe [GI_41327153-S] in brain cortex with no Alzheimer's interaction 1.1×10-10 19361613 (PMID) GRASP2 eQTL
cg23688719 (chr1:65935678) 3.8×10-8 10.1101/033084 (DOI) BIOS QTL cis-meQTLs
Gene expression of LEPROT (probeID ILMN_1661537) in cerebellum in Alzheimer's disease cases and controls 6.4×10-8 22685416 (PMID) GRASP2 eQTL
Gene expression of LEPROT in peripheral blood monocytes 9.6×10-7 20502693 (PMID) GRASP2 eQTL
Gene expression of LEPROT (probeID ILMN_1661537) in cerebellum in non-Alzheimer's disease samples 1.5×10-6 22685416 (PMID) GRASP2 eQTL
Serum ratio of (gamma-glutamylisoleucine*)/(scyllo-inositol) 1.4×10-5 21886157 (PMID) GRASP2 metabQTL
Gene expression of LEPROT in CD4+ lymphocytes 1.9×10-4 20833654 (PMID) GRASP2 eQTL
Autism 2.4×10-4 20663923 (PMID) GRASP2 nonQTL
Serum ratio of (1,3,7-trimethylurate)/(theobromine) 3.3×10-4 21886157 (PMID) GRASP2 metabQTL
Serum ratio of (cysteine-glutathione disulfide)/(scyllo-inositol) 4.7×10-4 21886157 (PMID) GRASP2 metabQTL